These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3151333)

  • 1. In vitro activity of ciprofloxacin.
    Ferrara A; Donnetta A; Grassi FA; Gialdroni Grassi G
    Chemioterapia; 1987 Jun; 6(2 Suppl):130-1. PubMed ID: 3151333
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative activities of three new antibacterial agents with aztreonam against gram-negative bacilli.
    Kafetzis DA; Legakis NJ
    Chemioterapia; 1987 Jun; 6(2 Suppl):110-2. PubMed ID: 3151330
    [No Abstract]   [Full Text] [Related]  

  • 3. Synergy studies of ciprofloxacin and other quinolone derivatives in combination with further antibiotics.
    Höffler U
    Chemioterapia; 1987 Jun; 6(2 Suppl):140-2. PubMed ID: 2855612
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus.
    Campos P; Vera A; Martin-Luengo F
    Chemioterapia; 1987 Jun; 6(2 Suppl):77-8. PubMed ID: 3151358
    [No Abstract]   [Full Text] [Related]  

  • 5. Ciprofloxacin in vitro activity alone and in combination against clinical isolates of glucose nonfermenting bacteria.
    Marklein G; Lotze G; Ungerechts J
    J Chemother; 1989 Jul; 1(4 Suppl):156-9. PubMed ID: 16312350
    [No Abstract]   [Full Text] [Related]  

  • 6. [Enoxacin and ciprofloxacin: in vitro effect on Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus].
    Roy C; Foz A; Segura C; Tirado M; Teixell M; Teruel D
    Med Clin (Barc); 1986 Jan; 86(1):1-3. PubMed ID: 2937983
    [No Abstract]   [Full Text] [Related]  

  • 7. Ciprofloxacin in combination with other antimicrobials.
    Eliopoulos GM; Eliopoulos CT
    Am J Med; 1989 Nov; 87(5A):17S-22S. PubMed ID: 2511757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro characterization of Ro 23-6240.
    Stobberingh E; Houben A; Van Boven C
    Chemioterapia; 1987 Jun; 6(2 Suppl):154-5. PubMed ID: 3151336
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin.
    Machka K; Milatovic D; Braveny I
    Chemioterapia; 1987 Jun; 6(2 Suppl):117-8. PubMed ID: 2978385
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro activity of meropenem in combination with ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
    Solak S; Willke A; Ergönül O; Tekeli E
    Int J Antimicrob Agents; 2005 Feb; 25(2):181-2. PubMed ID: 15664492
    [No Abstract]   [Full Text] [Related]  

  • 11. An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
    Segatore B; Perilli M; Larosa M; Setacci D; Celenza G; Amicosante G
    Int J Antimicrob Agents; 2007 Oct; 30(4):374-6. PubMed ID: 17659863
    [No Abstract]   [Full Text] [Related]  

  • 12. [In vitro activity of azthreonam (SQ 26.776) against Gram-negative bacteria].
    Landínez RJ; García Castro MA; Coladas N; Bratos MA; Kastanos N; Alvarez Alonso E
    Med Clin (Barc); 1984 Jan; 82(3):106-9. PubMed ID: 6431206
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro bactericidal activity of allicin combined with cefoperazone, tobramycin and ciprofloxacin.
    Cai Y; Wang R; An MM; Liang BB; Fang Y
    Int J Antimicrob Agents; 2008 Feb; 31(2):179-80. PubMed ID: 18083012
    [No Abstract]   [Full Text] [Related]  

  • 14. External otitis in divers: etiology and in vitro activity of ciprofloxacin and local agents.
    Dibb WL
    Chemioterapia; 1987 Jun; 6(2 Suppl):138-40. PubMed ID: 3509371
    [No Abstract]   [Full Text] [Related]  

  • 15. [A study of the in vitro sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa to 7 antimicrobial agents].
    Lynch MB; Mimica I; Valenzuela MC; Vilches A; Abarca S
    Rev Med Chil; 1972 Jan; 100(1):14-5. PubMed ID: 4622217
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa.
    Yamada S; Hyo Y; Ohmori S; Ohuchi M
    Chemotherapy; 2007; 53(3):202-9. PubMed ID: 17356268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
    Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
    J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with ciprofloxacin in vitro and in vivo.
    Giamarellou H; Efstratiou A; Tsagarakis J; Petrikkos G; Daikos GK
    Arzneimittelforschung; 1984; 34(12):1775-8. PubMed ID: 6442151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vitro activity of Ro 17-2301, a new monobactam antibiotic].
    Roy C; Foz A; Segura C; Tirado M; Teixell M
    Med Clin (Barc); 1985 Jun; 85(5):183-6. PubMed ID: 3927089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.